OX40L blockade cellular nanovesicles for autoimmune diseases therapy.
Fu Y, Wang L, Liu W, Yang L, Li L, Wang L, Sun X, Zhang ZR, Lin Q, Zhang L.
Fu Y, et al. Among authors: yang l.
J Control Release. 2021 Sep 10;337:557-570. doi: 10.1016/j.jconrel.2021.08.008. Epub 2021 Aug 8.
J Control Release. 2021.
PMID: 34371056